about
Specific transfection of inflamed brain by macrophages: a new therapeutic strategy for neurodegenerative diseasesExosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challengesThe role of lipid peroxidation in neurological disordersSustained extracellular signal-regulated kinase activation by 6-hydroxydopamine: implications for Parkinson's diseaseOxidative stress in skin fibroblasts cultures from patients with Parkinson's diseaseMultiple antioxidants in the prevention and treatment of Parkinson's disease.Role of oxidative stress and antioxidants in neurodegenerative diseases.The regulation of catalase activity by PPAR γ is affected by α-synuclein.Selenium intake, mood and other aspects of psychological functioning.Vitamin E. Neurochemistry and implications for neurodegeneration in Parkinson's disease.Exosomes as drug delivery vehicles for Parkinson's disease therapyRole of iron and iron chelation in dopaminergic-induced neurodegeneration: implication for Parkinson's disease.Age-related decline in the dopaminergic nigrostriatal system: the oxidative hypothesis and protective strategies.Neuroprotective clinical strategies for Parkinson's disease.An introduction to the free radical hypothesis in Parkinson's disease.Challenging conventional wisdom: the etiologic role of dopamine oxidative stress in Parkinson's disease.Blood-borne macrophage-neural cell interactions hitchhike on endosome networks for cell-based nanozyme brain delivery.Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson's disease: Involvement of mitochondrial dysfunctions and oxidative stress.L-DOPA treatment from the viewpoint of neuroprotection. Possible mechanism of specific and progressive dopaminergic neuronal death in Parkinson's disease.Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia.Glutathione-related enzymes in brain in Parkinson's disease.Delivery of Therapeutic Proteins via Extracellular Vesicles: Review and Potential Treatments for Parkinson's Disease, Glioma, and Schwannoma.A macrophage-nanozyme delivery system for Parkinson's disease.Oxidative stress in Parkinson's disease: a mechanism of pathogenic and therapeutic significance.The emerging role of nutrition in Parkinson's disease.Iron-dependent functions of mitochondria--relation to neurodegeneration.MPTP induced parkinsonian syndrome: long term follow-up and neurophysiological study.Recent updates in redox regulation and free radical scavenging effects by herbal products in experimental models of Parkinson's disease.Mechanisms underlying neuronal degeneration in Parkinson's disease: an experimental and theoretical treatise.Clues to the mechanism underlying dopamine cell death in Parkinson's diseaseAchieving the Promise of Therapeutic Extracellular Vesicles: The Devil is in Details of Therapeutic Loading.The endogenous toxin hypothesis of the etiology of Parkinson's disease and a pilot trial of high-dosage antioxidants in an attempt to slow the progression of the illness.Molecular changes in the postmortem parkinsonian brain.Metabolic Dysfunction in Parkinson's Disease: Bioenergetics, Redox Homeostasis and Central Carbon Metabolism.Peroxidases in the neural retina and pigment epithelium.Brain-targeted delivery of Tempol-loaded nanoparticles for neurological disorders.Oxidative modification of peroxiredoxin is associated with drug-induced apoptotic signaling in experimental models of Parkinson disease.1-methyl-4-phenylpyridinium neurotoxicity is attenuated by adenoviral gene transfer of human Cu/Zn superoxide dismutase.Oxidative stress in Parkinson's disease.Chronic exposure of homocysteine in mice contributes to dopamine loss by enhancing oxidative stress in nigrostriatum and produces behavioral phenotypes of Parkinson's disease.
P2860
Q21133553-B9FC3583-50AC-456A-97EC-92E70889C22AQ26740577-DFE00531-33D6-4F29-A9CF-2A25EE975C78Q26829767-649EF4DF-B92F-4FF2-B5D2-9C9432188EACQ28365464-31E04B14-5E6F-44D6-AA3B-04631862F879Q33722784-7615C843-5417-4D9D-B26C-953B866A1E3FQ33746725-362621ED-5CB3-452C-B9B0-428AE82AEE48Q34154938-B1873567-49E3-4AA4-B68D-FBEF2F46D384Q34286365-B06A4C46-4481-4FCE-AB76-A8A915077E5CQ35037314-EA1C9DDB-3A52-45D0-96A2-4DAE4FFAF394Q35534578-BFEF0CDD-8A38-46E9-AFA3-D8F85482E1D2Q35602589-5D6C982C-1FAE-430C-823C-58EC9E16B7E9Q35753846-EF56F4FE-8ADF-4442-9BBC-E74E8AC2DEEBQ35753858-9CC347A8-376F-4002-8D67-9481C2EED68CQ35753867-EAE01150-6961-49AB-8A55-85437DA61F7AQ35753876-9072256C-2426-4800-B50F-F1C395C1AB9DQ35973542-0C52E2BC-EB65-440D-82EB-8172F87583D1Q36063039-879820CC-91FB-4AD3-ADA6-601DB8DC8580Q36272936-50418F7B-6B2F-4E7D-B66D-9491CC0A7C02Q36285084-82B5C2B7-8DDE-4E94-BDBD-CB367C689D77Q36739461-41FBB23F-3AFF-4359-A44A-65EA99C3C7EFQ36739464-D10154F2-987F-4536-BA0A-41F04B0B0FA2Q36880469-FCBAE24A-032E-412D-B61D-8D3639DCF90EQ37179637-DDE12A6B-D946-4592-B5A5-FBE854C97AB7Q37348548-3AD3ECE7-99DB-4B1C-9A14-B184A1E2824CQ37622710-CA270625-A271-4389-916E-9055B0D09F66Q37821334-F9DD2257-7928-43F3-B4D7-7268A3F61B6DQ38021200-6C315752-7281-4089-AA84-3187D763ED5CQ38046734-F7EFE196-88DE-4F45-A558-490276A119B3Q38271772-0C7BE3BC-9036-41D5-AE02-A0DA233372BAQ38668883-5BDBF2CE-A942-47BA-A4DC-D5D0E52EE7A3Q38743388-A0E63AAB-0A42-46E2-8740-80CA8EFC2998Q38776432-C5186480-0612-48D2-B54D-0F9750AD71EFQ38887346-27E443B0-A7A3-4799-A918-F5EB1064DCB8Q39199926-BA09F809-5D76-41A3-82CF-D8114A3CE57EQ39213846-FB73C124-C6C5-46CF-A59C-6EAF1E4D0FAFQ39738982-77FEFC68-5C1F-476E-8F83-47AC6EAA495CQ40016546-5DD4C0E7-C020-43B6-BAFF-1D628B24F626Q40340160-A9657A55-0491-477A-9F24-3C90FF715150Q40538595-84950D74-0DE6-4D64-96A9-53D565A899B4Q41683178-2C015FC2-1EA4-4B25-8B99-547269532570
P2860
description
1975 nî lūn-bûn
@nan
1975年の論文
@ja
1975年学术文章
@wuu
1975年学术文章
@zh-cn
1975年学术文章
@zh-hans
1975年学术文章
@zh-my
1975年学术文章
@zh-sg
1975年學術文章
@yue
1975年學術文章
@zh
1975年學術文章
@zh-hant
name
Brain peroxidase and catalase in Parkinson disease.
@en
Brain peroxidase and catalase in Parkinson disease.
@nl
type
label
Brain peroxidase and catalase in Parkinson disease.
@en
Brain peroxidase and catalase in Parkinson disease.
@nl
prefLabel
Brain peroxidase and catalase in Parkinson disease.
@en
Brain peroxidase and catalase in Parkinson disease.
@nl
P2093
P1433
P1476
Brain peroxidase and catalase in Parkinson disease.
@en
P2093
P304
P356
10.1001/ARCHNEUR.1975.00490440064010
P577
1975-02-01T00:00:00Z